Adaptive SABR Boost Shows Promise in Advanced NSCLC Adaptive SABR Boost Shows Promise in Advanced NSCLC

Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news